Related Experiment Video
Updated: Feb 12, 2026

Applying Advanced In Vitro Culturing Technology to Study the Human Gut Microbiota
Published on: February 15, 2019
Increased Gut Microbiota Diversity in Patients With Retinitis Pigmentosa and Implications for Disease Phenotypes and
Tomoko Hasegawa1,2, Sachiko Iwai1, Hanako Ohashi Ikeda1,3
1Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Purpose:
Inflammation is often present in retinitis pigmentosa (RP) and is reported to affect visual outcome. Gut microbiota plays a crucial role in inflammatory diseases. This study aimed to elucidate the relationship between the gut microbiota and RP.
Methods:
The 16S rRNA gene sequencing analysis was performed on stool samples collected from 103 patients with RP and 64 healthy individuals. The α and β diversities of gut microbiota, along with relative abundances, were compared between patients and healthy individuals, as well as between patients with or without cystoid macular edema (CME). The RP model rd10 mice were treated with or without antibiotics starting at 7 days of age. Retinal structure and function were evaluated.
Results:
Gut microbiota diversity was higher in patients with RP than in healthy individuals (P < 0.001). Moreover, patients with CME had greater diversity than did those without CME and showed a higher abundance of Romboutsia and Ruminococcus (P < 0.05). Antibiotics-treated rd10 mice showed suppressed apoptosis, attenuated decrease of photoreceptors, and a significantly lower incidence of retinal detachment. Retinal function was significantly preserved in mice treated with antibiotics. In antibiotics-treated mice, the expression of Il-1β, Nlrp3, Caspase-1, pNFkb, pJNK, and pCREB1 was downregulated, suggesting suppression of the NLRP3 inflammasome.
Conclusions:
Patients with RP exhibited distinct gut microbiota characteristics compared to that of healthy individuals. Treatment with antibiotics attenuated disease progression in the RP model mouse. Modifying the gut microbiota may be a potential therapeutic strategy for modifying disease progression in RP in future investigations.
Insights
Retinitis pigmentosa (RP) patients show altered gut bacteria. Antibiotic treatment in RP mice improved retinal health by reducing inflammation, suggesting gut microbiota modulation as a potential therapy for RP.
Area of Science:
- Ophthalmology
- Microbiology
- Immunology
Background:
- Inflammation is a common feature in retinitis pigmentosa (RP), impacting visual outcomes.
- The gut microbiota significantly influences inflammatory processes in the body.
Purpose of the Study:
- To investigate the association between gut microbiota composition and retinitis pigmentosa.
- To explore the therapeutic potential of modulating gut microbiota in RP.
Main Methods:
- 16S rRNA gene sequencing of stool samples from 103 RP patients and 64 healthy controls.
- Comparison of gut microbiota diversity and abundance between groups, including RP patients with and without cystoid macular edema (CME).
- Evaluation of retinal structure and function in RP model mice treated with antibiotics.
Main Results:
- RP patients exhibited significantly higher gut microbiota diversity than healthy individuals.
- RP patients with CME showed greater diversity and increased abundance of specific bacteria (Romboutsia, Ruminococcus).
- Antibiotic treatment in RP mice preserved retinal function, reduced photoreceptor loss, suppressed apoptosis, and downregulated NLRP3 inflammasome pathway components.
Conclusions:
- Distinct gut microbiota profiles are observed in RP patients compared to healthy individuals.
- Antibiotic administration attenuated disease progression in an RP mouse model.
- Targeting the gut microbiota represents a promising therapeutic avenue for retinitis pigmentosa.
Related Concept Videos
Increasing Function
Cell Diversity
Multicellular...
Diversity of Archaea II
Diversity of Protists I
Diversity of Protists II
Diversity of Archaea I

